Register Here

On November 8, 2022, voters across the country were tasked with deciding the fate of numerous cannabis and psychedelics bills and initiatives. These included:

  • psychedelics regulation in Colorado
  • psilocybin licensing opt-out votes around Oregon
  • cannabis decriminalization votes in Texas
  • medical cannabis regulation in Arkansas
  • recreational cannabis regulation in Maryland
  • recreational cannabis regulation in Missouri
  • recreational cannabis regulation in North Dakota, and
  • recreational cannabis regulation in South Dakota.

Several of these efforts succeeded, others failed, and still others resulted in a mixed bag (some final; some pending at the time of publication of this post). You can view helpful summaries below:

Event description

On Tuesday, November 15, 2022 at 12:00 pm PST, Harris Bricken attorneys Vince Sliwoski (Portland) and Griffen Thorne (Los Angeles) will host a free, hour-long webinar analyzing the election results. We will break down a number of the state and local election outcomes and answer your questions about the impact of these new laws.

Please feel free to submit your questions in advance. Questions will also be taken throughout the presentation. See you Tuesday!

Canna Law Blog

Source link

You May Also Like

Australia: Police seize $1.5m in cocaine after man observed allegedly trying to bury drugs near Darwin CBD

NT Police say they have thwarted a significant drug operation after a man…

Best Ways To Detox After Halloween

Halloween brings a lot of things to mind, most of them being…

Canopy Growth sells Smiths Falls HQ back to Hershey “for approximately $53 million.”

CBC Cannabis company Canopy Growth Corp. announced Thursday it’s shutting down its…

Aelis Farma Receives a Positive Recommendation From the DSMB to Continue, With No Modification to the Protocol, the Phase 2b Clinical Study With AEF0117 in Cannabis Addiction – Medical Marijuana Program Connection

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS) (Paris:…